Cargando…

Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe (−/−) mice with hyperhomocysteinemia

AIMS/INTRODUCTION: An elevated level of plasma homocysteine has long been suspected as a metabolic risk factor for the development of atherosclerotic vascular diseases in diabetes. Berberine (BBR) has several preventive effects on cardiovascular diseases. The effects of BBR on atherosclerotic plaque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hongjun, He, Chengyan, Wang, Jingying, Li, Xiaoou, Yang, Zhaowei, Sun, Xiaoying, Fang, Ling, Liu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089944/ https://www.ncbi.nlm.nih.gov/pubmed/27181586 http://dx.doi.org/10.1111/jdi.12516

Ejemplares similares

Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice
por: Chen, Junwen, et al.
Publicado: (2014)

Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases
por: Wang, Chaoban, et al.
Publicado: (2022)

Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice
por: Zhi, Xiuling, et al.
Publicado: (2013)

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
por: Wang, Renqing, et al.
Publicado: (2017)

Hydrogen sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S‐sulfhydration in ApoE‐knockout atherosclerotic mice
por: Fan, Jinhui, et al.
Publicado: (2019)

Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE(−/−) mice
por: Yin, Tieying, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
por: Fuior, Elena Valeria, et al.
Publicado: (2023)

Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology
por: Liu, Li-Li, et al.
Publicado: (2015)

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
por: Park, Hyung Kyu, et al.
Publicado: (2015)

The role of peroxisome proliferator-activated receptor gamma in prostate cancer
por: Elix, Catherine, et al.
Publicado: (2018)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
por: Alexander, Stephen PH, et al.
Publicado: (2012)

Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma
por: Weidner, Philip, et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
por: Dallongeville, Jean, et al.
Publicado: (2009)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2014)

Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2()
por: Lee, Yoon Kwang, et al.
Publicado: (2018)

Monocytes/macrophages activation contributes to b-gamma-glutamyltransferase accumulation inside atherosclerotic plaques
por: Belcastro, Eugenia, et al.
Publicado: (2015)

The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease
por: Zhang, Ji-Yong, et al.
Publicado: (2021)

Cordycepin stimulates autophagy in macrophages and prevents atherosclerotic plaque formation in ApoE(-/-) mice
por: Li, Xin, et al.
Publicado: (2017)

Berberine Attenuates Arterial Plaque Formation in Atherosclerotic Rats with Damp-Heat Syndrome via Regulating Autophagy
por: Ke, Xiao, et al.
Publicado: (2020)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE(−/−) Mice
por: Kim, Sungmin, et al.
Publicado: (2022)

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone
por: Nava-Villalba, Mario, et al.
Publicado: (2015)

Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity
por: Sáez, María E, et al.
Publicado: (2008)

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma
por: Zhang, G Y, et al.
Publicado: (2005)

Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
por: Hwang, Su Jin, et al.
Publicado: (2011)

Kinetic characterization of selective peroxisome-proliferator-activated receptor gamma modulators in vitro
por: Knape, T, et al.
Publicado: (2012)

Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders
por: Ren, Ping, et al.
Publicado: (2015)

Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma
por: Takeuchi, Akihiko, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics
por: Motawi, T. K., et al.
Publicado: (2017)

Binding of Per- and Polyfluoro-alkyl Substances to Peroxisome Proliferator-Activated Receptor Gamma
por: Almeida, Nuno M. S., et al.
Publicado: (2021)

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in ApoE(−/−) Mice
por: Bekkering, Siroon, et al.
Publicado: (2022)

Initiation of the expression of peroxisome proliferator - activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH
por: Long, Mary J, et al.
Publicado: (2009)

Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
por: Fumery, Mathurin, et al.
Publicado: (2017)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

MicroRNA-33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE(−/−) Mice
por: Horie, Takahiro, et al.
Publicado: (2012)

Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice
por: Grootaert, Mandy O. J., et al.
Publicado: (2016)

Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe(–/–) mice
por: Leipner, Julia, et al.
Publicado: (2021)

Triflumizole Is an Obesogen in Mice that Acts through Peroxisome Proliferator Activated Receptor Gamma (PPARγ)
por: Li, Xia, et al.
Publicado: (2012)

Tacrolimus reduces atherosclerotic plaque formation in ApoE(−/−) mice by inhibiting NLRP3 inflammatory corpuscles
por: Li, Xiao, et al.
Publicado: (2020)

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
por: Garcia-Bates, Tatiana M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9ic4t2tbnoq5splkir2ev53bft